Amoéba S.A. (EPA:ALMIB)

Market Cap	62.29M
Revenue (ttm)	601.60K
Net Income (ttm)	-6.59M
Shares Out	49.63M
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	745,781
Average Volume	823,199
Open	1.267
Previous Close	1.255
Day's Range	1.208 - 1.338
52-Week Range	0.390 - 1.444
Beta	0.62
RSI	63.96
Earnings Date	Jun 24, 2025

About Amoéba

Amoéba S.A. develops biological biocides for the prevention of microbiological risk for water, crop protection and health sectors. It develops applications using amoeba Willaertia magna C2c Maky. The company was incorporated in 2010 and is based in Chassieu, France.

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2010
• Employees: 20
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMIB

Financial Performance

In 2024, Amoéba's revenue was 601,600, a decrease of -9.44% compared to the previous year's 664,310. Losses were -6.59 million, -53.90% less than in 2023.